a16z Capital Management, L.L.C. 13F: Quarter-over-Quarter Portfolio Changes
a16z Capital Management, L.L.C. reported a disclosed portfolio value of approximately $1.3 billion in its latest SEC Form 13F-HR filing for Q1 2026, down 18.3% quarter on quarter. Over the quarter, the manager initiated 4 new positions, bought more shares in 1 holding, trimmed 2 holdings, and exited 1 position.
a16z Capital Management, L.L.C.'s top buy was a new stake in Damora Therapeutics INC (DMRA) , equal to 2.5% of the disclosed portfolio. Its top sell was Omada Health INC (OMDA) . The manager sold 33.3% of its previously reported shares, reducing the position's portfolio weight by 1.2 percentage points.
New PositionsQ1 2026
Securities disclosed for the first time in Q1 2026 that were not present in the prior 13F-HR filing.
| Company | Ticker | Initial Portfolio Weight | History |
|---|---|---|---|
| DAMORA THERAPEUTICS INC | DMRA | 2.5% | History → |
| AKTIS ONCOLOGY INC | AKTS | 0.6% | Holders → |
| BITGO HOLDINGS INC | BTGO | 0.4% | Holders → |
| IP STRATEGY HOLDINGS INC | UNKNOWN | 0.0% | Holders → |
Top BuysQ1 2026
The manager's top buys among existing positions in Q1 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.
Top SellsQ1 2026
The manager's top sells among positions it retained in Q1 2026. Ranked by portfolio-weight impact. Full exits are listed separately.
| Company | Ticker | Portfolio Weight Change | Shares Sold | History |
|---|---|---|---|---|
| OMADA HEALTH INC | OMDA | -1.2% | 33.3% | Holders → |
| FIGMA INC | FIG | -12.2% | 1.4% | History → |
Full ExitsQ1 2026
Positions present in the prior 13F-HR filing that no longer appear in Q1 2026.
| Company | Ticker | Last-Reported Portfolio Weight |
|---|---|---|
| HERITAGE COMM CORP | XHC | 0.0% |
Net Portfolio Value ChangeQ1 2026
- $1.6BPrior quarter
- $1.3BCurrent quarter
- $-0.3BNet delta
- -18.3%% change
Methodology & FAQ
How a16z Capital Management, L.L.C. Quarterly Changes Are Computed
All deltas are sourced from sequential SEC Form 13F-HR filings for a16z Capital Management, L.L.C.: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description — including how confidential treatment filings are handled — is documented in the Methodology.
What stocks did a16z Capital Management, L.L.C. buy in Q1 2026?
In Q1 2026, a16z Capital Management, L.L.C. initiated 4 new positions (DAMORA THERAPEUTICS INC (DMRA), AKTIS ONCOLOGY INC (AKTS), BITGO HOLDINGS INC (BTGO), IP STRATEGY HOLDINGS INC (UNKNOWN)); bought more shares of NAVAN INC (NAVN).
What stocks did a16z Capital Management, L.L.C. sell in Q1 2026?
In Q1 2026, a16z Capital Management, L.L.C. fully sold 1 position (HERITAGE COMM CORP (XHC)); reduced holdings in OMADA HEALTH INC (OMDA), FIGMA INC (FIG).
Which positions did a16z Capital Management, L.L.C. initiate in Q1 2026?
a16z Capital Management, L.L.C. established 4 new positions in Q1 2026: DAMORA THERAPEUTICS INC (DMRA, 2.5%), AKTIS ONCOLOGY INC (AKTS, 0.6%), BITGO HOLDINGS INC (BTGO, 0.4%), IP STRATEGY HOLDINGS INC (UNKNOWN, 0.0%).
Which existing positions saw the largest allocation increases for a16z Capital Management, L.L.C. in Q1 2026?
Of 1 existing position with share-count increases in Q1 2026, the largest were: NAVAN INC (NAVN, +-0.5% weight, +3.8% shares).
Which positions did a16z Capital Management, L.L.C. fully exit in Q1 2026?
a16z Capital Management, L.L.C. fully exited 1 position in Q1 2026: HERITAGE COMM CORP (XHC, last-reported weight 0.0%).
Which existing positions saw the largest allocation reductions for a16z Capital Management, L.L.C. in Q1 2026?
Of 2 existing positions with share-count reductions in Q1 2026, the largest were: OMADA HEALTH INC (OMDA, -1.2% weight, -33.3% shares), FIGMA INC (FIG, -12.2% weight, -1.4% shares).
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.